Mass Device -- Embattled ReGen Biologics Inc. files voluntary petitions for Chapter 11 bankruptcy protection and announces a $1 million private placement from one of its largest investors. FDA, ReGen Biologics
ReGen Biologics Inc. filed for Chapter 11 bankruptcy protection with the U.S. Bankruptcy Court for the District of Delaware.
